Thomas Szekeres Selected Research

Thomas Szekeres Research Topics

Disease

38	Neoplasms (Cancer) 10/2017 - 04/2002
21	Leukemia 10/2017 - 04/2002
15	Breast Neoplasms (Breast Cancer) 01/2022 - 07/2005
5	Inflammation (Inflammations) 04/2023 - 01/2011
4	Liver Diseases (Liver Disease) 04/2023 - 01/2021
4	Pancreatic Neoplasms (Pancreatic Cancer) 10/2013 - 02/2008
4	Colonic Neoplasms (Colon Cancer) 02/2009 - 04/2002
3	Portal Hypertension 04/2023 - 01/2021
3	Heart Diseases (Heart Disease) 10/2022 - 06/2010
3	Myocardial Infarction 10/2022 - 10/2007
3	Stroke (Strokes) 10/2022 - 01/2019
3	Heart Failure 10/2021 - 10/2007
3	Melanoma (Melanoma, Malignant) 03/2015 - 06/2010
3	Neoplasm Metastasis (Metastasis) 03/2015 - 07/2013
3	Carcinoma (Carcinomatosis) 11/2012 - 07/2005
2	Critical Illness (Critically Ill) 03/2024 - 10/2007
2	Fibrosis (Cirrhosis) 04/2023 - 12/2021
2	COVID-19 03/2023 - 12/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 01/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 01/2019
2	Pulmonary Embolism 10/2021 - 10/2007
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 08/2015 - 01/2015
2	Coronary Disease (Coronary Heart Disease) 06/2012 - 01/2008
2	Lymphoma (Lymphomas) 03/2009 - 07/2005
2	Glioma (Gliomas) 10/2004 - 04/2002
2	Leukemia L1210 08/2004 - 04/2002
1	Hemolysis 03/2024
1	End Stage Liver Disease 04/2023
1	Acute-On-Chronic Liver Failure 04/2023
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Kidney Diseases (Kidney Disease) 10/2021
1	Thrombosis (Thrombus) 10/2021
1	Wounds and Injuries (Trauma) 10/2021

Drug/Important Bio-Agent (IBA)

19	ResveratrolIBA 03/2015 - 03/2005
15	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 10/2017 - 08/2002
14	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2017 - 08/2002
7	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 03/2005
6	Hormones (Hormone)IBA 10/2021 - 09/2007
6	EnzymesIBA 10/2013 - 04/2002
4	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2020
4	C-Reactive ProteinIBA 04/2023 - 01/2020
4	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2011 - 01/2007
4	3,3',4,4',5,5'-hexahydroxystilbeneIBA 06/2010 - 09/2006
4	StilbenesIBA 06/2010 - 10/2006
4	Floxuridine (FUdR)FDA LinkGeneric 07/2005 - 09/2003
3	Gallic AcidIBA 01/2018 - 01/2007
3	Antineoplastic Agents (Antineoplastics)IBA 10/2017 - 04/2002
3	Proteins (Proteins, Gene)FDA Link 08/2015 - 10/2009
3	digalloylresveratrolIBA 10/2013 - 02/2009
3	Phosphates (Orthophosphate)IBA 06/2012 - 08/2004
3	3,3',4,5'-tetrahydroxystilbeneIBA 12/2010 - 09/2006
3	AvemarIBA 03/2009 - 02/2005
3	AntioxidantsIBA 08/2008 - 09/2006
2	AldosteroneIBA 12/2021 - 10/2021
2	ReninIBA 12/2021 - 10/2021
2	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2021 - 10/2007
2	pro-brain natriuretic peptide (1-76)IBA 10/2021 - 01/2009
2	Natriuretic PeptidesIBA 10/2021 - 10/2007
2	Messenger RNA (mRNA)IBA 08/2015 - 03/2010
2	Anaplastic Lymphoma KinaseIBA 08/2015 - 01/2015
2	PolyphenolsIBA 01/2015 - 10/2009
2	triphosphoric acid (triphosphate)IBA 01/2015 - 12/2010
2	Sulfates (Sulfates, Inorganic)IBA 09/2014 - 03/2010
2	Gemcitabine FDA Link 11/2012 - 02/2008
2	Estrogens (Estrogen)FDA Link 09/2012 - 12/2010
2	SulfotransferasesIBA 03/2010 - 03/2008
2	Fluorouracil (Carac)FDA LinkGeneric 02/2009 - 08/2004
2	CytidineIBA 02/2009 - 03/2005
2	3'-C-methyladenosineIBA 07/2008 - 07/2005
2	Deuterium Oxide (Heavy Water)IBA 02/2008 - 09/2005
2	3,4,5-trihydroxybenzamidoximeIBA 02/2006 - 08/2002
2	tiazofurinIBA 03/2005 - 04/2002
2	Carmustine (FIVB)FDA Link 10/2004 - 08/2004
2	3,4-dihydroxybenzohydroxamic acidIBA 10/2004 - 08/2004
2	3-(1-deoxyribofuranosyl)benzamideIBA 04/2002 - 04/2002
1	Hemoglobins (Hemoglobin)IBA 03/2024
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2024
1	AmmoniaIBA 04/2023
1	Complement System Proteins (Complement)IBA 03/2023
1	VaccinesIBA 03/2023
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	human ERBB2 proteinIBA 01/2022
1	pertuzumabIBA 01/2022
1	trastuzumab deruxtecanIBA 01/2022
1	Prothrombin (Factor II)IBA 12/2021
1	AntigensIBA 12/2021
1	PlasminogenIBA 12/2021
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 12/2021
1	fibrin fragment D (D-dimer)IBA 12/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 12/2021
1	von Willebrand FactorIBA 12/2021
1	Interleukin-6 (Interleukin 6)IBA 12/2021
1	Arginine Vasopressin (Argipressin)IBA 10/2021
1	AngiotensinsIBA 10/2021

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 01/2011 - 04/2002
7	Therapeutics 01/2022 - 04/2002
2	Combination Drug Therapy (Combination Chemotherapy) 03/2005 - 10/2004
1	Extracorporeal Membrane Oxygenation 03/2024
1	Percutaneous Coronary Intervention 10/2022